How to Help Your Patients Save Money on Tranexamic Acid: A Provider's Guide to Savings Programs

Medication cost is one of the most common barriers to treatment adherence — and tranexamic acid for heavy menstrual bleeding is no exception. At retail prices that can exceed $127 for a 30-tablet supply, uninsured or underinsured patients may skip doses, delay refills, or abandon the prescription entirely. This guide equips you with the specific tools and language to help your patients reduce their out-of-pocket costs for tranexamic acid in 2026.

Understanding the Tranexamic Acid Cost Landscape

Tranexamic acid is a generic drug with a sometimes surprising retail price. The brand-name Lysteda was discontinued in 2020, and the current generic market includes several manufacturers. Despite generic availability, retail prices without a coupon remain high:

Average retail: $127–$203 for a 30-tablet supply (650 mg), depending on the source

With GoodRx: As low as $27–$28 for 30 tablets — a reduction of up to 78%

With SingleCare: ~$30 for 30 tablets

Insurance (Medicare Part D, Tier 3): Copay typically $0–$30; prior auth generally not required for HMB indication

Mail-order (90-day supply): Often $0–$30 per fill through insurance plan's preferred mail-order pharmacy

No Manufacturer Savings Programs Exist

It is important for providers to know that no manufacturer copay cards or patient assistance programs (PAPs) currently exist for generic tranexamic acid. The brand-name program through Ferring Pharmaceuticals ended when Lysteda was discontinued in 2020. Patients seeking manufacturer assistance should be redirected to the third-party discount and mail-order options outlined in this guide.

Strategy 1: GoodRx and Third-Party Coupons

GoodRx is the most widely accessible savings tool for generic tranexamic acid and reduces cost by up to 78%. For patients who pick up prescriptions at retail pharmacies, this is the simplest intervention you can recommend.

Clinical workflow tip:

Add a standard note to your TXA prescription paperwork or after-visit summary: "Check GoodRx.com or goodrx.com for savings coupons — tranexamic acid 650 mg can cost as low as $27 at participating pharmacies."

Alert patients that GoodRx and insurance cannot be combined — they should compare and use whichever is lower.

For high-deductible plan patients, GoodRx often beats the insurance price before the deductible is met.

Strategy 2: 90-Day Supply via Mail-Order Pharmacy

For patients who use tranexamic acid consistently each month, a 90-day mail-order prescription provides both cost savings and access reliability. Most major insurance plans offer lower copays (often $0–$30 for a 90-day fill vs. $10–$30 monthly for retail) and the medication arrives by mail, eliminating the monthly pharmacy trip and potential stock-out problem.

How to implement:

Write a 90-day prescription with 3 refills where clinically appropriate for stable HMB patients.

Advise patients to check with their insurer's preferred mail-order pharmacy (Express Scripts, OptumRx, CVS Caremark, etc.) for pricing.

Note that the first fill often must be done at retail; subsequent refills can be switched to mail-order.

Strategy 3: Mark Cuban Cost Plus Drugs

Mark Cuban's Cost Plus Drug Company (costplusdrugs.com) offers generic medications at drug manufacturing cost plus a transparent 15% markup with a $5 pharmacy fee. For patients who are comfortable with online ordering and mail delivery, this can provide competitively priced tranexamic acid without insurance.

This option works well for uninsured patients, those in the deductible phase of high-deductible health plans, and patients who have difficulty accessing retail pharmacies.

Strategy 4: State Pharmaceutical Assistance Programs

For low-income, uninsured patients who are not eligible for Medicaid, state pharmaceutical assistance programs (SPAPs) and resources like NeedyMeds (needymeds.org) and RxAssist can help identify available subsidies. While tranexamic acid is unlikely to qualify for disease-specific PAPs (since it's a generic with no manufacturer program), state programs may cover prescription costs for eligible patients.

Strategy 5: Formulary Tier Appeals and PA Avoidance

For the FDA-approved heavy menstrual bleeding indication, tranexamic acid typically does not require prior authorization. If a patient's plan does require PA, the process should be straightforward given the strong evidence base and FDA approval. Reference ACOG clinical guidance and the 2009 FDA approval to support the PA request.

If a plan places tranexamic acid on a higher tier than expected, consider requesting a tier exception, particularly for patients with contraindications to hormonal alternatives. Documenting the non-hormonal nature of TXA and the clinical rationale for its use is often sufficient.

Addressing Access and Stock Issues Alongside Cost

Cost and access are often intertwined barriers. Patients who save money on their prescription but can't find it in stock still won't fill it. Direct patients experiencing access issues to medfinder for Providers, which calls pharmacies on their behalf to identify which locations can fill the prescription. This reduces prescription abandonment due to combined cost and stock barriers.

Quick-Reference Savings Conversation Guide

Use this quick guide when prescribing tranexamic acid at the point of care:

Insured patients: Check copay at your pharmacy. If deductible is not met, compare with GoodRx — GoodRx may be cheaper. Ask about 90-day mail-order supply.

Uninsured patients: Use GoodRx or SingleCare at retail (~$27-$30 per cycle) or Cost Plus Drugs with home delivery. Check NeedyMeds for state assistance programs.

High-deductible patients: GoodRx is almost always cheaper before deductible is met. Once deductible is met, compare insurance copay vs. GoodRx.

Medicare patients: Typically Tier 3 on Part D, usually $0-$30 copay. GoodRx cannot be combined with Medicare — but may be used instead.

Summary

Tranexamic acid cost barriers are real but solvable. With no manufacturer PAP available, the most impactful tools are GoodRx coupons, 90-day mail-order prescriptions, and Cost Plus Drugs. Incorporating a brief savings conversation at the point of care — or including a printed resource with the after-visit summary — significantly improves prescription fill rates and treatment adherence. For the patient-facing version of this guide, see our patient savings guide for tranexamic acid.